Abstract
Recent studies have shown that, in addition to its well-known erythropoietic effects, erythropoietin has anti-inflammatory, neuroprotective, and neurotrophic effects in different tissues including the retina and optic nerve. In this review, we made a comprehensive search to define the therapeutic potential of erythropoietin in retinal and optic nerve diseases that lead to blindness.
Keywords: Erythropoietin, erythropoietic effect, neuroprotective, optic neuritis, optic nerve, retina.
CNS & Neurological Disorders - Drug Targets
Title:Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
Volume: 14 Issue: 9
Author(s): Bekir Kucuk, Yakup Cevik, Ugur Acar and Gungor Sobaci
Affiliation:
Keywords: Erythropoietin, erythropoietic effect, neuroprotective, optic neuritis, optic nerve, retina.
Abstract: Recent studies have shown that, in addition to its well-known erythropoietic effects, erythropoietin has anti-inflammatory, neuroprotective, and neurotrophic effects in different tissues including the retina and optic nerve. In this review, we made a comprehensive search to define the therapeutic potential of erythropoietin in retinal and optic nerve diseases that lead to blindness.
Export Options
About this article
Cite this article as:
Kucuk Bekir, Cevik Yakup, Acar Ugur and Sobaci Gungor, Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases, CNS & Neurological Disorders - Drug Targets 2015; 14 (9) . https://dx.doi.org/10.2174/1871527314666150821104800
DOI https://dx.doi.org/10.2174/1871527314666150821104800 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Drug Delivery to the Back of the Eye Following Topical Administration: An Update on Research and Patenting Activity
Recent Patents on Drug Delivery & Formulation Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research
Current Pharmaceutical Biotechnology Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features
Current Neurovascular Research Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Current Drug Targets Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science Neuropilin Signalling in Vascular Development and Pathology
Current Angiogenesis (Discontinued) Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy Pharmacological Benefits of Active Components of Natural Products Against Traumatic Brain Injury - A Review
Current Pharmacogenomics and Personalized Medicine New Development and Application of Ultrasound Targeted Microbubble Destruction in Gene Therapy and Drug Delivery
Current Gene Therapy Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies
Current Pharmaceutical Design Proliferative Retinopathies: Animal Models and Therapeutic Opportunities
Current Neurovascular Research Endothelial Remodelling and Intracellular Calcium Machinery
Current Molecular Medicine Anti-Diabetic Effects of Isolated Lipids from Natural Sources through Modulation of Angiogenesis
Current Molecular Pharmacology Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma
Mini-Reviews in Medicinal Chemistry